Tissue Regenerative Materials – Medical Devices Pipeline Product Landscape, 2021

Tissue Regenerative Material is a biomaterial component which facilitates regeneration of lost periodontal hard and soft tissue. GlobalData's Medical Devices sector report, "Tissue Regenerative Materials – Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Tissue Regenerative Materials pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Tissue Regenerative Materials Pipeline Landscape report provides key information and data related to:

Extensive coverage of the Tissue Regenerative Materials under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Tissue Regenerative Materials pipeline products.

Review of Recent Developments in the segment / industry

The Tissue Regenerative Materials Pipeline Landscape report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Glaucoma Drainage Device sunder development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Tissue Regenerative Materials under development

– the report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– the report reviews the major players involved in the development of Tissue Regenerative Materials and list all their pipeline projects

– the coverage of pipeline products based on various stages of development ranging from Early development to Approved / Issued stage

– the report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Tissue Regenerative Materials under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

Colorado Therapeutics, LLC

credentis AG

Histocell SL

Indian Institute of Technology Bombay

Maxigen Biotech Inc

Nobel Biocare Services AG

Novatissue SAS

Orthocell Ltd

Orthorebirth Co Ltd

Polytechnic University of Catalonia

Straumann Holding AG

SurgaColl Technologies Ltd

SweetBio, Inc.

Tigran Technologies AB

Trimph Technology Pty Ltd

Table of Contents

1 Table of Contents

2 Introduction 7

2.1 Tissue Regenerative Materials Overview 7

3 Products under Development 8

3.1 Tissue Regenerative Materials – Pipeline Products by Stage of Development 8

3.2 Tissue Regenerative Materials – Pipeline Products by Territory 9

3.3 Tissue Regenerative Materials – Pipeline Products by Regulatory Path 10

3.4 Tissue Regenerative Materials – Pipeline Products by Estimated Approval Date 11

3.5 Tissue Regenerative Materials – Ongoing Clinical Trials 12

4 Tissue Regenerative Materials – Pipeline Products under Development by Companies 13

4.1 Tissue Regenerative Materials Companies – Pipeline Products by Stage of Development 13

4.2 Tissue Regenerative Materials – Pipeline Products by Stage of Development 14

5 Tissue Regenerative Materials Companies and Product Overview 15

5.1 Colorado Therapeutics, LLC Company Overview 15

5.1.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 15

5.2 credentis AG Company Overview 16

5.2.1 credentis AG Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 Histocell SL Company Overview 17

5.3.1 Histocell SL Pipeline Products & Ongoing Clinical Trials Overview 17

5.4 Indian Institute of Technology Bombay Company Overview 18

5.4.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 18

5.5 Maxigen Biotech Inc Company Overview 19

5.5.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.6 Nobel Biocare Services AG Company Overview 20

5.6.1 Nobel Biocare Services AG Pipeline Products & Ongoing Clinical Trials Overview 20

5.7 Novatissue SAS Company Overview 21

5.7.1 Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview 21

5.8 Orthocell Ltd Company Overview 22

5.8.1 Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

5.9 Orthorebirth Co Ltd Company Overview 23

5.9.1 Orthorebirth Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.10 Polytechnic University of Catalonia Company Overview 24

5.10.1 Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview 24

5.11 Straumann Holding AG Company Overview 25

5.11.1 Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview 25

5.12 SurgaColl Technologies Ltd Company Overview 26

5.12.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

5.13 SweetBio, Inc. Company Overview 27

5.13.1 SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

5.14 Tigran Technologies AB Company Overview 28

5.14.1 Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview 28

5.15 Trimph Technology Pty Ltd Company Overview 29

5.15.1 Trimph Technology Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

6 Tissue Regenerative Materials- Recent Developments 32

6.1 Apr 29, 2021: First-quarter 2021 report Media Release 32

7 Appendix 36

7.1 Methodology 36

7.2 About GlobalData 39

7.3 Contact Us 39

List of Tables

Tissue Regenerative Materials – Pipeline Products by Stage of Development 8

Tissue Regenerative Materials – Pipeline Products by Territory 9

Tissue Regenerative Materials – Pipeline Products by Regulatory Path 10

Tissue Regenerative Materials – Pipeline Products by Estimated Approval Date 11

Tissue Regenerative Materials – Ongoing Clinical Trials 12

Tissue Regenerative Materials Companies – Pipeline Products by Stage of Development 13

Tissue Regenerative Materials – Pipeline Products by Stage of Development 14

Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 15

Xenograft Implant – Dental – Product Status 15

Xenograft Implant – Dental – Product Description 15

credentis AG Pipeline Products & Ongoing Clinical Trials Overview 16

CUROLOX Perio – Product Status 16

CUROLOX Perio – Product Description 16

Histocell SL Pipeline Products & Ongoing Clinical Trials Overview 17

HR018-Neofibrin – Product Status 17

HR018-Neofibrin – Product Description 17

Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 18

Electrospun Scaffold – Product Status 18

Electrospun Scaffold – Product Description 18

Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 19

MaxiGuide – Product Status 19

MaxiGuide – Product Description 19

Nobel Biocare Services AG Pipeline Products & Ongoing Clinical Trials Overview 20

Bone Inductive Implant – Product Status 20

Bone Inductive Implant – Product Description 20

Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview 21

OrthoNovaOss – Product Status 21

OrthoNovaOss – Product Description 21

Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

Striate+ – Product Status 22

Striate+ – Product Description 22

Orthorebirth Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

GCT-101 – Product Status 23

GCT-101 – Product Description 23

Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview 24

Inorganic Dental Cement – Product Status 24

Inorganic Dental Cement – Product Description 24

Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview 25

Soft Tissue Control Implant – Product Status 25

Soft Tissue Control Implant – Product Description 25

SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

DentaColl – Product Status 26

DentaColl – Product Description 26

SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

SweetBio GTR (Guided Tissue Regeneration) Membrane – Product Status 27

SweetBio GTR (Guided Tissue Regeneration) Membrane – Product Description 27

Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview 28

Tigran Porous Titanium Granules – Alveolar Fillings – Product Status 28

Tigran Porous Titanium Granules – Alveolar Fillings – Product Description 28

Trimph Technology Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

TrimphDent – Product Status 29

TrimphDent – Product Description 29

Trimph Technology Pty Ltd – Ongoing Clinical Trials Overview 30

TrimphDent – PET-B: Post Extraction Use of Trimphdent Part B. A Comparator Controlled Clinical Investigation Comparing the Bone Healing Capability of the Investigational Product "Trimphdent plus Biooss" (TDB) and the Gold Standard of Care Comparator "Bioosscollagen" (Bioosscol), for Adults Who Have Been Treatment Planned for Tooth Extraction/S and Implant Placement at the Same Extraction Site/s 31

List of Figures

Tissue Regenerative Materials – Pipeline Products by Stage of Development 8

Tissue Regenerative Materials – Pipeline Products by Territory 9

Tissue Regenerative Materials – Pipeline Products by Regulatory Path 10

Tissue Regenerative Materials – Pipeline Products by Estimated Approval Date 11

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports